Your browser doesn't support javascript.
loading
Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity.
Spiegelberg, Linda; van Hoof, Stefan J; Biemans, Rianne; Lieuwes, Natasja G; Marcus, Damiënne; Niemans, Raymon; Theys, Jan; Yaromina, Ala; Lambin, Philippe; Verhaegen, Frank; Dubois, Ludwig J.
Afiliação
  • Spiegelberg L; Department of Precision Medicine, The M-Lab, GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University, Maastricht, the Netherlands.
  • van Hoof SJ; Department of Radiation Oncology (Maastro), GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Biemans R; Department of Precision Medicine, The M-Lab, GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University, Maastricht, the Netherlands.
  • Lieuwes NG; Department of Precision Medicine, The M-Lab, GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University, Maastricht, the Netherlands.
  • Marcus D; Department of Precision Medicine, The M-Lab, GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University, Maastricht, the Netherlands.
  • Niemans R; Department of Precision Medicine, The M-Lab, GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University, Maastricht, the Netherlands.
  • Theys J; Department of Precision Medicine, The M-Lab, GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University, Maastricht, the Netherlands.
  • Yaromina A; Department of Precision Medicine, The M-Lab, GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University, Maastricht, the Netherlands.
  • Lambin P; Department of Precision Medicine, The M-Lab, GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University, Maastricht, the Netherlands.
  • Verhaegen F; Department of Radiation Oncology (Maastro), GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Dubois LJ; Department of Precision Medicine, The M-Lab, GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University, Maastricht, the Netherlands. Electronic address: ludwig.dubois@maastrichtuniversity.nl.
Radiother Oncol ; 141: 247-255, 2019 12.
Article em En | MEDLINE | ID: mdl-31431383
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mostardas de Fosforamida / Radiossensibilizantes / Neoplasias Esofágicas / Adenocarcinoma / Carcinoma de Células Escamosas de Cabeça e Pescoço / Nitroimidazóis Limite: Animals / Female / Humans / Male Idioma: En Revista: Radiother Oncol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mostardas de Fosforamida / Radiossensibilizantes / Neoplasias Esofágicas / Adenocarcinoma / Carcinoma de Células Escamosas de Cabeça e Pescoço / Nitroimidazóis Limite: Animals / Female / Humans / Male Idioma: En Revista: Radiother Oncol Ano de publicação: 2019 Tipo de documento: Article